[Federal Register Volume 61, Number 35 (Wednesday, February 21, 1996)]
[Notices]
[Pages 6664-6665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-3764]



=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application to Withdraw from Listing 
and Registration; (Incyte Pharmaceuticals, Inc., Common Stock, $.001 
Par Value) Fine No. 1-2400

February 14, 1996.
    Incyte Pharmaceuticals, Inc. (``Company'') has filed an application 
with the Securities and Exchange Commission (``Commission''), pursuant 
to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and 
rule 12d2-2(d) promulgated thereunder, to withdraw the above specified 
security (``Security'') from listing and registration on the American 
Stock Exchange, Inc. (``Amex'').
    The reasons alleged in the application for withdrawing the Security 
from listing and registration include the following:
    According to the Company, its Board of Directors unanimously 
approved resolutions on November 30, 1995 to withdraw the Security from 
listing on the Amex and instead, to list the Security on the Nasdaq 
National Market (``Nasdaq/NM'').
    The decision of the Board followed a thorough study of the 
management of the matter and was based upon the belief that the 
Company's stockholders would benefit from greater liquidity and broader 
research coverage by having the Security listed on the Nasdaq National 
Market rather than the Amex.
    Any interested person may, on or before March 7, 1996 submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549, facts bearing upon whether the 
application has been made in accordance with the rules of the exchanges 
and what terms, if any, should be imposed by the Commission for the 
protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

[[Page 6665]]

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 96-3764 Filed 2-20-96; 8:45 am]
BILLING CODE 8010-01-M